Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
TCR-transgenic T cells and YB-1-based oncolytic virotherapy improve survival in a preclinical Ewing sarcoma xenograft mouse model.
Front Immunol. 2024 Jan 22;15:1330868. doi: 10.3389/fimmu.2024.1330868. eCollection 2024.
Front Immunol. 2024.
PMID: 38318175
Free PMC article.
The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma.
Schober SJ, Schoening C, Eck J, Middendorf C, Lutsch J, Knoch P, von Ofen AJ, Gassmann H, Thiede M, Hauer J, Kolk A, Mantwill K, Gschwend JE, Burdach SEG, Nawroth R, Thiel U, Holm PS.
Schober SJ, et al. Among authors: von ofen aj.
Clin Cancer Res. 2023 May 15;29(10):1996-2011. doi: 10.1158/1078-0432.CCR-22-1961.
Clin Cancer Res. 2023.
PMID: 36892582
Item in Clipboard
YB-1-based oncolytic virotherapy in combination with CD47 blockade enhances phagocytosis of pediatric sarcoma cells.
von Ofen AJ, Thiel U, Eck J, Gassmann H, Thiede M, Hauer J, Holm PS, Schober SJ.
von Ofen AJ, et al.
Front Oncol. 2024 Jan 31;14:1304374. doi: 10.3389/fonc.2024.1304374. eCollection 2024.
Front Oncol. 2024.
PMID: 38357194
Free PMC article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.